One Agent Better for RAS Blockade (CME/CE)
NEW YORK CITY (MedPage Today) -- The use of two agents to block the renin-angiotensin system (RAS) -- as opposed to one -- appears to have little benefit and has significant negative effects, a meta-analysis showed. (Source: MedPage Today State Required CME)

Doctors learn about cancer follow-up care
Doctors need to be better educated about the significant long-term side effects of chemotherapy that may affect their cancer survivor patients, according to new research. (Source: WDSU.com - Health)